• Media type: E-Article
  • Title: Cost-effectiveness of abdominal aortic aneurysm repair: A systematic review
  • Contributor: Jonk, Yvonne C.; Kane, Robert L.; Lederle, Frank A.; MacDonald, Roderick; Cutting, Andrea H.; Wilt, Timothy J.
  • imprint: Cambridge University Press (CUP), 2007
  • Published in: International Journal of Technology Assessment in Health Care
  • Language: English
  • DOI: 10.1017/s0266462307070316
  • ISSN: 0266-4623; 1471-6348
  • Keywords: Health Policy
  • Origination:
  • Footnote:
  • Description: <jats:p><jats:bold>Objectives:</jats:bold>A systematic review of the cost-effectiveness of abdominal aortic aneurysm (AAA) repair was conducted. Although open surgery has been considered the gold standard for prevention of AAA rupture, emerging less-invasive endovascular treatments have led to increased interest in evaluating the cost and cost-effectiveness of treatment options.</jats:p><jats:p><jats:bold>Methods:</jats:bold>A systematic review of studies published in MEDLINE between 1999 and 2005 reporting the cost and/or cost-effectiveness of endovascular and/or open surgical repair of nonruptured AAAs was conducted. Case series studies with less than fifty patients per treatment were excluded.</jats:p><jats:p><jats:bold>Results:</jats:bold>Of twenty eligible articles, three were randomized controlled trials, twelve case series, four Markov models, and one systematic review. Regardless of time frame, all studies found that endovascular repair costs more than open surgery. Although the high cost of the endovascular prosthesis was partially offset by reduced intensive care, hospital length of stay, operating time, blood transfusions, and perioperative complications, hospital costs were still greater for endovascular than open surgical repair. For patients medically fit for open surgery, mid-term costs were greater for endovascular repair with no difference in overall survival or quality of life. For patients medically unfit for open surgery, endovascular repair costs more than no intervention with no difference in survival.</jats:p><jats:p><jats:bold>Conclusions:</jats:bold>Although conclusions regarding the cost-effectiveness of AAA treatment options are time dependent and vary by institutional perspective, from a societal perspective, endovascular repair is not currently cost-effective for patients with large AAA regardless of medical fitness.</jats:p>